Graves’ Disease and Treatment Effects on Warfarin Anticoagulation
Open Access
- 4 June 2014
- journal article
- case report
- Published by Wiley in Case Reports in Medicine
- Vol. 2014, 1-6
Abstract
Background. Hyperthyroidism causes an increased hypoprothrombinemic response to warfarin anticoagulation. Previous studies have demonstrated that patients with hyperthyroidism require lower dosages of warfarin to achieve a therapeutic effect. As hyperthyroidism is treated and euthyroidism is approached, patients may require increasing warfarin dosages to maintain appropriate anticoagulation. We describe a patient’s varying response to warfarin during treatment of Graves’ disease.Case Presentation. A 48-year-old African American female presented to the emergency room with tachycardia, new onset bilateral lower extremity edema, gradual weight loss, palpable goiter, and generalized sweating over the prior 4 months. She was admitted with Graves’ disease and new onset atrial fibrillation. Primary stroke prophylaxis was started using warfarin; the patient developed a markedly supratherapeutic INR likely due to hyperthyroidism. After starting methimazole, her free thyroxine approached euthyroid levels and the INR became subtherapeutic. She remained subtherapeutic over several months despite steadily increasing dosages of warfarin. Immediately following thyroid radioablation and discontinuation of methimazole, the patient’s warfarin dose and INR stabilized.Conclusion. Clinicians should expect an increased response to warfarin in patients with hyperthyroidism and close monitoring of the INR is imperative to prevent adverse effects. As patients approach euthyroidism, insufficient anticoagulation is likely without vigilant follow-up, INR monitoring, and increasing warfarin dosages.Keywords
This publication has 17 references indexed in Scilit:
- Oral Anticoagulant TherapyChest, 2012
- Effect of methimazole on warfarin anticoagulation in a case of Graves' diseaseBlood Coagulation & Fibrinolysis, 2008
- Effect of Graves’ Disease and Methimazole on Warfarin AnticoagulationAnnals of Pharmacotherapy, 2006
- HypothyroidismSouthern Medical Journal, 1989
- Oral Anticoagulants and Drugs Which Alter Thyroid FunctionDrug Intelligence & Clinical Pharmacy, 1980
- Warfarin-induced hypoprothrombinemia. Potentiation by hyperthyroidism1975
- The relationship between thyroid function and anticoagulant therapyThe American Journal of Cardiology, 1963
- Effect of Sodium Dextrothyroxine in Patients Receiving AnticoagulantsNew England Journal of Medicine, 1962
- HYPOPROTHROMBINEMIA DUE TO PROPYLTHIOURACIL THERAPYJAMA, 1960
- The effect of thyroid function on the prothrombin time response to warfarin in ratsCellular and Molecular Life Sciences, 1957